Image For Activity Cover
SCD Risk Stratification in Restrictive, Infiltrative and Rare Cardiomyopathies
Description
This is a session on the SCD risk and need to implant a primary prevention ICD with infiltrative and rare cardiomyopathies.
Learning Objectives
  • Summarize reasons for needing more data on the outcomes of primary prevention ICDs in patients with infiltrative CM.
  • Synthesize content related to why existing data on the role of primary prevention ICDs may not apply to many patients with infiltrative CM.
  • Describe the challenges and opportunities related to conducting RCTs in this area.
Session Chair(s)
Cara Pellegrini, MD
Werner Jung, MD
Presentation
Hypertrophic Obstructive Cardiomyopathy - Contemporary Strategies for SCD Risk Assessment
Presenter(s): Olubadewa Fatunde, MD, MPH

SCD Risk in Amyloidosis - Bridging Imaging, Electrophysiology and Biomarkers
Presenter(s): Bharat Kantharia, MD

Risk Stratification and Device Selection in Cardiac Sarcoid
Presenter(s): Jordana Kron, MD

Risk Stratification in Idiopathic Inflammatory Cardiomyopathy
Presenter(s): Enrico Ammirati, Andre d'Avila, MA, MD, PhD

Disclosures
Olubadewa Fatunde:
  • Nothing Relevant to Disclose
Bharat Kantharia:
  • Nothing Relevant to Disclose
Jordana Kron:
  • Nothing Relevant to Disclose
Enrico Ammirati:
  • LEXEO Therapeutics Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
  • Cytokinetics (Honoraria/Speaking/Consulting Fee - Consulting)
  • Kiniksa (Honoraria/Speaking/Consulting Fee - Consulting)
  • AstraZeneca (Honoraria/Speaking/Consulting Fee - Consulting)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.
Education Framework
Ventricular Tachyarrhythmias
   --   Implantable Cardioverter-defibrillators (ICDs)
      --   225. Know the indications and contraindications for implantation of an ICD for primary prevention of sudden cardiac death in patients with ischemic and nonischemic cardiomyopathy as well as other arrhythmogenic conditions (including channelopathies and other cardiomyopathies) and for secondary prevention of sudden cardiac death.
Summary
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By